oligonucleotide therapy
Eli Lilly Partners with Genetic Leap in $409 Million AI-Driven Drug Development Deal
Eli Lilly, Genetic Leap, AI-powered drug deal, oligonucleotide therapy, pharmaceutical partnership
BioNTech Expands ADC Alliance with MediLink, Investing $1.8 Billion
BioNTech, MediLink, ADC alliance, $1.8 billion, oligonucleotide therapy, gene therapy, molecular biology